Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.94% |
| 2 | Technology | 8.23% |
| 3 | Healthcare | 7.53% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
3151
PUT
DELISTED
Select Medical
SEM
| $3.1M | ﹤0.01% |
+232,000
| New | +$3M |
|
|
USER
3152
DELISTED
UserTesting, Inc.
USER
| $3.1M | ﹤0.01% |
+413,369
| New | +$2.64M |
|
3153
Virgin Galactic
SPCE
$446M
| $3.1M | ﹤0.01% |
+44,555
| New | +$4.16M |
|
3154
Beam Therapeutics
BEAM
$3.03B
| $3.1M | ﹤0.01% |
79,154
-88,951
| -53% | -$3.98M |
|
3155
PUT
IAMGOLD
IAG
$11.8B
| $3.1M | ﹤0.01% |
1,200,000
-500,000
| -29% | -$869K |
|
|
LIVB
3156
DELISTED
LIV Capital Acquisition Corp. II Class A Ordinary Shares
LIVB
| $3.1M | ﹤0.01% |
301,700
-8
| -0% | -$81 |
|
3157
JetBlue
JBLU
$1.81B
| $3.08M | ﹤0.01% |
475,748
-297,225
| -38% | -$2.17M |
|
3158
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
| $3.08M | ﹤0.01% |
40,963
-1,100
| -3% | -$82.2K |
|
3159
BCB Bancorp
BCBP
$156M
| $3.08M | ﹤0.01% |
171,055
+44,900
| +36% | +$841K |
|
3160
Ryder
R
$9.43B
| $3.07M | ﹤0.01% |
36,709
-178,156
| -83% | -$15M |
|
|
CMRC
3161
CALL
Commerce.com Inc Series 1
CMRC
$207M
| $3.06M | ﹤0.01% |
350,000
+100,000
| +40% | +$1.08M |
|
3162
Radware
RDWR
$1.2B
| $3.06M | ﹤0.01% |
154,911
+134,940
| +676% | +$2.82M |
|
3163
FormFactor
FORM
$7.94B
| $3.05M | ﹤0.01% |
137,029
-262,358
| -66% | -$6.11M |
|
3164
PUT
Spectrum Brands
SPB
$2.04B
| $3.05M | ﹤0.01% |
+50,000
| New | +$2.52M |
|
|
CELL
3165
DELISTED
PhenomeX Inc. Common Stock
CELL
| $3.04M | ﹤0.01% |
1,136,261
+1,050,046
| +1,218% | +$2.77M |
|
3166
Donnelley Financial Solutions
DFIN
$1.19B
| $3.02M | ﹤0.01% |
78,205
-11,050
| -12% | -$414K |
|
|
FNA
3167
DELISTED
Paragon 28, Inc.
FNA
| $3.02M | ﹤0.01% |
158,204
-606,778
| -79% | -$11.5M |
|
|
BYTSU
3168
DELISTED
BYTE Acquisition Corp. Units
BYTSU
| $3.02M | ﹤0.01% |
300,000
| – | – |
|
3169
Northern Trust
NTRS
$34.2B
| $3M | ﹤0.01% |
33,938
-308,321
| -90% | -$27M |
|
|
CFIV
3170
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $3M | ﹤0.01% |
299,027
+26,645
| +10% | +$267K |
|
3171
H.B. Fuller
FUL
$3.03B
| $2.99M | ﹤0.01% |
+41,794
| New | +$3.02M |
|
3172
Monte Rosa Therapeutics
GLUE
$1.14B
| $2.99M | ﹤0.01% |
393,150
+367,221
| +1,416% | +$3.06M |
|
|
HOLX
3173
CALL
DELISTED
Hologic
HOLX
| $2.99M | ﹤0.01% |
40,000
-310,000
| -89% | -$22.1M |
|
3174
Arcus Biosciences
RCUS
$3.72B
| $2.99M | ﹤0.01% |
144,627
+132,066
| +1,051% | +$3.63M |
|
|
NXH
3175
Neighborhood Intelligence Inc
NXH
$375M
| $2.98M | ﹤0.01% |
169,131
+130,383
| +336% | +$2.8M |
|
Similar funds
Israel Englander's Q4 2022 Portfolio in Review
As of Q4 2022, Israel Englander held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander's Q4 2022 filing shows 848 new, 2,516 increased, 2,491 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Israel Englander added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Israel Englander's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Israel Englander fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Israel Englander's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Israel Englander opened 848 new positions and closed 1,332 in Q4 2022.
- Israel Englander's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.